Form 4: Vera Therapeutics CEO Acquires Shares and Stock Options
SEC Form 4
Marshall Fordyce, CEO of Vera Therapeutics, reports acquisition of shares and stock options.
Summary
- On February 18, 2025, Marshall Fordyce, the President and CEO of Vera Therapeutics, acquired 80,750 shares of Class A Common Stock.
- These shares are related to restricted stock units (RSUs) under the company's 2021 Equity Incentive Plan, vesting in equal installments annually from February 20, 2026, to 2029.
- Fordyce also acquired stock options for 161,500 shares of Class A Common Stock at an exercise price of $29.18.
- These options vest monthly, starting March 18, 2025, over a four-year period, expiring on February 17, 2035.
- Following these transactions, Fordyce directly owns 224,353 shares of Class A Common Stock and indirectly owns 222,030 shares through a GRAT.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a standard regulatory filing. The CEO's increased stake could be seen as mildly positive, but it's part of a pre-determined compensation plan.
Positives
- The CEO's acquisition of shares and stock options could be interpreted as a positive signal, indicating confidence in the company's future performance.
Future Outlook
The vesting schedules for both the RSUs and stock options suggest a long-term commitment from the CEO to the company's success.
Industry Context
Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.
Stakeholder Impact
- The CEO's increased stake aligns his interests with those of shareholders.
Key Dates
| Date | Description |
|---|---|
| 02/18/2025 | Date of transaction: Acquisition of shares and stock options. |
| 02/20/2025 | Date of Form 4 signature. |
| 02/20/2026 | First vesting date for RSUs (one-fourth of the total). |
| 02/20/2027 | Second vesting date for RSUs (one-fourth of the total). |
| 02/20/2028 | Third vesting date for RSUs (one-fourth of the total). |
| 02/20/2029 | Final vesting date for RSUs (one-fourth of the total). |
| 03/18/2025 | First vesting date for stock options (1/48th of the total). |
| 02/17/2035 | Expiration date for the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.